Natixis Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$167M Sell
618,220
-55,551
-8% -$16.5M 0.23% 93
2025
Q4
$222M Sell
673,771
-61,027
-8% -$20.7M 0.32% 61
2025
Q3
$254M Buy
734,798
+302,113
+70% +$91.4M 0.37% 41
2025
Q2
$135M Sell
432,685
-251,722
-37% -$96.2M 0.21% 102
2025
Q1
$358M Sell
684,407
-61,021
-8% -$31.2M 0.66% 21
2024
Q4
$377M Buy
745,428
+2,493
+0.3% +$1.42M 0.7% 18
2024
Q3
$434M Buy
742,935
+73,515
+11% +$41.6M 0.85% 16
2024
Q2
$341M Buy
669,420
+129,468
+24% +$63.5M 0.74% 17
2024
Q1
$267M Sell
539,952
-124,358
-19% -$63.2M 0.61% 24
2023
Q4
$350M Buy
664,310
+50,021
+8% +$26.7M 0.92% 10
2023
Q3
$310M Buy
614,289
+63,008
+11% +$31M 0.95% 11
2023
Q2
$265M Buy
551,281
+56,397
+11% +$27.6M 0.82% 14
2023
Q1
$234M Sell
494,884
-28,246
-5% -$13.6M 0.8% 13
2022
Q4
$277M Buy
523,130
+26,705
+5% +$14.1M 1.05% 5
2022
Q3
$251M Buy
496,425
+54,903
+12% +$28.9M 1.06% 7
2022
Q2
$227M Buy
441,522
+18,736
+4% +$9.41M 1% 8
2022
Q1
$216M Buy
422,786
+26,828
+7% +$12.9M 0.82% 13
2021
Q4
$199M Buy
395,958
+24,200
+7% +$11M 0.76% 14
2021
Q3
$145M Sell
371,758
-113,679
-23% -$47.1M 0.6% 26
2021
Q2
$194M Sell
485,437
-847
-0.2% -$338K 0.91% 11
2021
Q1
$181M Buy
486,284
+29,832
+7% +$10.3M 0.94% 10
2020
Q4
$160M Sell
456,452
-30,224
-6% -$10.1M 0.92% 10
2020
Q3
$152M Buy
486,676
+11,713
+2% +$3.6M 0.95% 14
2020
Q2
$140M Buy
474,963
+92,394
+24% +$26.5M 0.93% 14
2020
Q1
$95.4M Buy
382,569
+16,914
+5% +$4.65M 0.78% 21
2019
Q4
$107M Buy
365,655
+35,050
+11% +$9.17M 0.76% 19
2019
Q3
$71.8M Sell
330,605
-48,658
-13% -$11.7M 0.57% 30
2019
Q2
$92.5M Buy
379,263
+35,560
+10% +$8.55M 0.76% 19
2019
Q1
$85M Sell
343,703
-35,917
-9% -$9.16M 0.74% 18
2018
Q4
$94.6M Sell
379,620
-1,513
-0.4% -$400K 0.93% 16
2018
Q3
$101M Sell
381,133
-11,340
-3% -$2.95M 0.89% 15
2018
Q2
$96.3M Sell
392,473
-36,661
-9% -$8.8M 0.92% 13
2018
Q1
$91.8M Buy
429,134
+8,057
+2% +$1.84M 0.91% 14
2017
Q4
$92.8M Sell
421,077
-11,754
-3% -$2.49M 0.95% 14
2017
Q3
$84.8M Sell
432,831
-238
-0.1% -$46K 0.9% 14
2017
Q2
$80.3M Buy
433,069
+26,077
+6% +$4.57M 0.87% 16
2017
Q1
$66.8M Buy
406,992
+13,121
+3% +$2.15M 0.74% 20
2016
Q4
$63M Buy
393,871
+20,488
+5% +$3.06M 0.76% 17
2016
Q3
$52.3M Sell
373,383
-23,302
-6% -$3.26M 0.68% 22
2016
Q2
$56M Buy
396,685
+27,074
+7% +$3.61M 0.77% 18
2016
Q1
$47.6M Buy
369,611
+67,155
+22% +$7.94M 0.71% 23
2015
Q4
$35.6M Buy
302,456
+12,740
+4% +$1.49M 0.58% 29
2015
Q3
$33.6M Buy
289,716
+25,554
+10% +$3.06M 0.58% 27
2015
Q2
$32.2M Buy
264,162
+18,236
+7% +$2.16M 0.55% 23
2015
Q1
$29.1M Sell
245,926
-9,040
-4% -$1M 0.51% 24
2014
Q4
$25.8M Sell
254,966
-1,154
-0.5% -$109K 0.48% 22
2014
Q3
$22.1M Sell
256,120
-35,482
-12% -$3M 0.44% 28
2014
Q2
$23.8M Buy
291,602
+8,200
+3% +$645K 0.34% 39
2014
Q1
$23.2M Buy
283,402
+23,779
+9% +$1.79M 0.36% 37
2013
Q4
$19.6M Buy
259,623
+17,648
+7% +$1.27M 0.32% 48
2013
Q3
$17.3M Buy
241,975
+38,264
+19% +$2.74M 0.32% 54
2013
Q2
$13.3M Buy
+203,711
New +$12.7M 0.27% 87

Other funds holding UNH

Natixis Advisors's UNH Position: Q1 2026 in Review

Natixis Advisors reduced its UnitedHealth (UNH) stake by 8.2% in Q1 2026, selling an estimated $16.5M and leaving 618,220 shares worth $167M. The position accounts for 0.23% of the portfolio, ranked #93.

Natixis Advisors first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $434M in Q3 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Natixis Advisors held 618,220 shares of UnitedHealth worth $167M as of Q1 2026.
  • Natixis Advisors sold 55,551 UnitedHealth shares in Q1 2026, an estimated $16.5M.
  • UnitedHealth made up 0.23% of Natixis Advisors's portfolio in Q1 2026, its #93 holding.
  • Natixis Advisors first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • Natixis Advisors's UnitedHealth position peaked at $434M in Q3 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Natixis Advisors's 13F filing for Q1 2026, filed 13 May 2026.